Antithyroid drug induced agranulocytosis: what still we need to learn ?
| Autor: | Khalid Fouad Mauzen, Ebtesam Ba-Essa, Asirvatham Alwin Robert, Liaqat Ali Chaudhry |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
Oral dose
Drug medicine.medical_specialty Pediatrics Antithyroid drugs medicine.medical_treatment media_common.quotation_subject 030209 endocrinology & metabolism Case Report Hyperthyroidism agranulocytosis granulocyte colony stimulating factor 03 medical and health sciences 0302 clinical medicine medicine Sore throat media_common lcsh:R5-920 ATD-antithyroid drugs business.industry lcsh:Public aspects of medicine Antithyroid agent Granulocytosis lcsh:RA1-1270 General Medicine medicine.disease Surgery Granulocyte colony-stimulating factor stomatognathic diseases Carbimazole 030220 oncology & carcinogenesis medicine.symptom lcsh:Medicine (General) business medicine.drug |
| Zdroj: | The Pan African Medical Journal Pan African Medical Journal; Vol 23, No 1 (2016) The Pan African Medical Journal, Vol 23, Iss 27 (2016) |
| ISSN: | 1937-8688 |
| Popis: | Antithyroid drugs (ATDs) induced agranulocytosis is a rare but life threatening condition. We report a 29 years Filipino female diagnosed as having hyperthyroidism with normal base line blood counts, liver and renal profile. She was started on maximum 60mg (20mg TID) oral dose of carbimazole since one month by her treating physician. Exactly after one month of treatment she presented to emergency room (ER) with fever, sore throat and generalized weakness for several days.Pan African Medical Journal 2016; 23 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|